Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Anxiolytic-like property of risperidone and olanzapine as examined in multiple measures of fear in rats.

Sun T, He W, Hu G, Li M.

Pharmacol Biochem Behav. 2010 May;95(3):298-307. doi: 10.1016/j.pbb.2010.02.005. Epub 2010 Feb 16.

2.
3.

Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.

Qiao J, Zhang Q, Li M.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:177-85. doi: 10.1016/j.pnpbp.2013.10.005. Epub 2013 Oct 16.

4.

Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic.

Yokoyama F, Yamauchi M, Oyama M, Okuma K, Onozawa K, Nagayama T, Shinei R, Ishikawa M, Sato Y, Kakui N.

Psychopharmacology (Berl). 2009 Aug;205(2):177-87. doi: 10.1007/s00213-009-1528-1. Epub 2009 Apr 9.

PMID:
19357839
6.

Olanzapine and risperidone disrupt conditioned avoidance responding by selectively weakening motivational salience of conditioned stimulus: further evidence.

Zhang C, Fang Y, Li M.

Pharmacol Biochem Behav. 2011 Mar;98(1):155-60. doi: 10.1016/j.pbb.2010.12.018. Epub 2010 Dec 29.

7.
9.

Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.

Knoll AT, Meloni EG, Thomas JB, Carroll FI, Carlezon WA Jr.

J Pharmacol Exp Ther. 2007 Dec;323(3):838-45. Epub 2007 Sep 6.

10.

Long-lasting sensitization induced by repeated risperidone treatment in adolescent Sprague-Dawley rats: a possible D2 receptor mediated phenomenon?

Qiao J, Gao J, Shu Q, Zhang Q, Hu G, Li M.

Psychopharmacology (Berl). 2014 Apr;231(8):1649-59. doi: 10.1007/s00213-013-3386-0. Epub 2013 Dec 21.

11.

Olanzapine counteracts stress-induced anxiety-like behavior in rats.

Locchi F, Dall'olio R, Gandolfi O, Rimondini R.

Neurosci Lett. 2008 Jun 20;438(2):146-9. doi: 10.1016/j.neulet.2008.04.017. Epub 2008 Apr 10.

PMID:
18455305
12.

An investigation of the behavioral mechanisms of antipsychotic action using a drug-drug conditioning paradigm.

Li M, He W, Mead A.

Behav Pharmacol. 2009 Mar;20(2):184-94. doi: 10.1097/FBP.0b013e32832a8f66.

PMID:
19322074
13.
14.

Time course of the antipsychotic effect and the underlying behavioral mechanisms.

Li M, Fletcher PJ, Kapur S.

Neuropsychopharmacology. 2007 Feb;32(2):263-72. Epub 2006 May 31.

15.

Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils.

Heldt SA, Davis M, Ratti E, Corsi M, Trist D, Ressler KJ.

Behav Pharmacol. 2009 Oct;20(7):584-95. doi: 10.1097/FBP.0b013e32832ec594.

16.

The brain orexin system and almorexant in fear-conditioned startle reactions in the rat.

Steiner MA, Lecourt H, Jenck F.

Psychopharmacology (Berl). 2012 Oct;223(4):465-75. Epub 2012 May 17.

PMID:
22592903
17.

Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice.

Smith KS, Engin E, Meloni EG, Rudolph U.

Neuropharmacology. 2012 Aug;63(2):250-8. doi: 10.1016/j.neuropharm.2012.03.001. Epub 2012 Mar 21.

18.

Avoidance-suppressing effect of antipsychotic drugs is progressively potentiated after repeated administration: an interoceptive drug state mechanism.

Mead A, Li M.

J Psychopharmacol. 2010 Jul;24(7):1045-53. doi: 10.1177/0269881109102546. Epub 2009 Mar 27.

PMID:
19329544
19.

Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze.

Pinheiro SN, Del-Ben CM, Zangrossi H Jr, Graeff FG.

J Psychopharmacol. 2008 Mar;22(2):132-7. doi: 10.1177/0269881107079866. Epub 2008 Jan 21.

PMID:
18208911
20.

Effects of TRH on acoustic startle, conditioned fear and active avoidance in rats.

Thompson BL, Rosen JB.

Neuropeptides. 2000 Feb;34(1):38-44.

PMID:
10688967
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk